# FDA 483 - Blood Bank of Delmarva, A Division of New York Blood Center, Inc. - November 12, 2019

Source: https://www.keypedia.com/records/483/blood-bank-of-delmarva-a-division-of-new-york-blood-center-inc/453dae35-3f66-43ef-b3e9-de309dbaed17

> FDA 483 for Blood Bank of Delmarva, A Division of New York Blood Center, Inc. on November 12, 2019. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Blood Bank of Delmarva, A Division of New York Blood Center, Inc.
- Inspection Date: 2019-11-12
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - East II
- Summary: An FDA inspection of Blood Bank of Delmarva, A Division of New York Blood Center, Inc. in Cheverly, MD, revealed significant deficiencies in their blood and blood component distribution processes. The firm failed to consistently perform and document visual inspections of blood products prior to shipment and upon receipt. Additionally, there was a lack of adequate quality control review for production and control records before product release or distribution.

## Related Officers

- [La-tasha M. Gunter](https://www.keypedia.com/people/la-tasha-m-gunter/db9cd9cf-db0a-4c31-9f7c-24760750f34d)

Company: https://www.keypedia.com/companies/blood-bank-of-delmarva-a-division-of-new-york-blood-center-inc/b37b0021-f26c-40ed-882d-8400e3d2a1dc

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-ii/a9ab7e08-db36-4350-a7d7-6a61dc61250e